Zydus Hospira Oncology Private Limited — Irinotecan Exporter Profile
Indian Pharmaceutical Exporter · #8 for Irinotecan · $690.4K export value · DGFT Verified
Zydus Hospira Oncology Private Limited is the #8 Indian exporter of Irinotecan with $690.4K in export value and 22 verified shipments. Zydus Hospira Oncology Private Limited holds a 1.7% market share in Irinotecan exports across 9 countries. The company exports 5 pharmaceutical products worth $4.7M across 2 therapeutic categories.
Zydus Hospira Oncology Private Limited — Irinotecan Export Profile: Buyers & Destinations
Where Does Zydus Hospira Oncology Private Limited Export Irinotecan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SINGAPORE | $110.0K | 3 | 26.2% |
| HONG KONG | $100.0K | 2 | 23.8% |
| TAIWAN | $67.9K | 2 | 16.2% |
| UNITED STATES | $50.0K | 1 | 11.9% |
| BELGIUM | $40.8K | 1 | 9.7% |
| CANADA | $37.0K | 4 | 8.8% |
| CHINA | $9.0K | 4 | 2.1% |
| PHILIPPINES | $3.5K | 1 | 0.8% |
| CZECH REPUBLIC | $1.7K | 4 | 0.4% |
Zydus Hospira Oncology Private Limited exports Irinotecan to 9 countries. The largest destination is SINGAPORE accounting for 26.2% of Zydus Hospira Oncology Private Limited's Irinotecan shipments, followed by HONG KONG (23.8%) and TAIWAN (16.2%). These destinations reflect Zydus Hospira Oncology Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Irinotecan from Zydus Hospira Oncology Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PFIZER SERVICE COMPANY BV | CZECH REPUBLIC | $248.1K | 11 |
| XXIZEXXSERXXCE XXMPAXX BV | SINGAPORE | $162.7K | 7 |
| XXINSXXW RXXEARXX AND XXVELXXMENXX(BEXXINGXXLIMITED | CHINA | $4.5K | 2 |
| CLINSNOW RESEARCH DEVELOPMENT BEIJING LIMITED | CHINA | $4.5K | 2 |
Zydus Hospira Oncology Private Limited supplies Irinotecan to 4 buyers globally. The largest buyer is PFIZER SERVICE COMPANY BV (CZECH REPUBLIC), followed by XXIZEXXSERXXCE XXMPAXX BV (SINGAPORE) and XXINSXXW RXXEARXX AND XXVELXXMENXX(BEXXINGXXLIMITED (CHINA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Irinotecan Export Value and How Much Does Zydus Hospira Oncology Private Limited Contribute?
India exported $37.5M worth of Irinotecan through 2,905 shipments from 164 suppliers to 111 countries, serving 495 buyers globally. Zydus Hospira Oncology Private Limited contributes $690.4K to this total, accounting for 1.7% of India's Irinotecan exports. Zydus Hospira Oncology Private Limited ships Irinotecan to 9 countries through 4 buyers.
What Is the Average Shipment Value for Zydus Hospira Oncology Private Limited's Irinotecan Exports?
Zydus Hospira Oncology Private Limited's average Irinotecan shipment value is $31.4K per consignment, based on 22 shipments totaling $690.4K. The largest destination is SINGAPORE (26.2% of Zydus Hospira Oncology Private Limited's Irinotecan exports).
How Does Zydus Hospira Oncology Private Limited Compare to Other Indian Irinotecan Exporters?
Zydus Hospira Oncology Private Limited ranks #8 among 164 Indian Irinotecan exporters with a 1.7% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($14.7M), FRESENIUS KABI ONCOLOGY LIMITED ($10.4M), EUGIA PHARMA SPECIALITIES LIMITED ($4.4M). Zydus Hospira Oncology Private Limited processed 22 shipments to 9 destination countries.
What Irinotecan Formulations Does Zydus Hospira Oncology Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IRINOTECAN HCL INJ. 100MG-SG-F000054116 | $110.0K | 3 |
| IRINOTECAN HCL INJ.100MG-HK-F000035889 | $100.0K | 2 |
| IRINOTECAN HCL INJ.100MG-TW-F000054117 | $67.9K | 2 |
| IRINOTECAN HCL INJ. 100MG US -F000031798 | $50.0K | 1 |
| IRINOTECAN HCLINJ.100MG-UK-F000056986 | $40.8K | 1 |
| IRINOTECAN HCL INJ. 500MG CA-F000211360 | $30.2K | 2 |
| IRINOTECAN HCL INJ. 100MG CA-F000211291 | $6.9K | 2 |
| CAMPTOSAR (IRINOTECAN) INJECTION | $4.5K | 2 |
| CAMPTOSAR IRINOTECAN INJECTION | $4.5K | 2 |
| IRINOTECAN HCL INJ.100MG - PH-F000035162 | $3.5K | 1 |
Zydus Hospira Oncology Private Limited exports 12 distinct Irinotecan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRINOTECAN HCL INJ. 100MG-SG-F000054116 with 3 shipments worth $110.0K.
How Does Zydus Hospira Oncology Private Limited Compare to Nearest Irinotecan Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | VENUS REMEDIES LIMITED | $1.3M | 110 | 16 | $11.6K |
| 6 | ACCURE LABS PRIVATE LIMITED | $1.0M | 20 | 1 | $50.0K |
| 8 | ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED ★ | $690.4K | 22 | 9 | $31.4K |
| 7 | JODAS EXPOIM PRIVATE LIMITED | $600.0K | 12 | 2 | $50.0K |
| 10 | INTAS PHARMACEUTICALS LTD | $327.1K | 21 | 7 | $15.6K |
Zydus Hospira Oncology Private Limited ranks #8 among 164 Indian Irinotecan exporters. Average shipment value of $31.4K compared to the market average of $228.7K. The closest competitors by value are VENUS REMEDIES LIMITED and ACCURE LABS PRIVATE LIMITED.
Which Indian Ports Ship Irinotecan Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 300 | 10.3% |
| SAHAR AIR | 296 | 10.2% |
| AHEMDABAD AIR ACC (INAMD4) | 252 | 8.7% |
| MUNDRA SEA (INMUN1) | 217 | 7.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 207 | 7.1% |
| DELHI AIR | 205 | 7.1% |
| AHEMDABAD AIR | 205 | 7.1% |
| MUNDRA SEA | 152 | 5.2% |
What Other Oncology Products Does Zydus Hospira Oncology Private Limited Export?
Zydus Hospira Oncology Private Limited also exports these oncology products. Each links to the detailed product page.
About Zydus Hospira Oncology Private Limited
Zydus Hospira Oncology Private Limited exports 5 products worth $4.7M. Beyond Irinotecan, top products include Gemcitabine, Oxaliplatin, Docetaxel, Cytarabine. View the complete Zydus Hospira Oncology Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Irinotecan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Irinotecan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Hospira Oncology Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 22 individual customs records matching Zydus Hospira Oncology Private Limited exporting Irinotecan, covering 12 formulations to 9 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 111+ countries, 495+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Irinotecan Export Data from Zydus Hospira Oncology Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Hospira Oncology Private Limited's Irinotecan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Hospira Oncology Private Limited
Full Company Profile →
5 products · $4.7M total trade · 2 categories
Irinotecan Stats
Company Overview
Top Products by Zydus Hospira Oncology Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Hospira Oncology Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Irinotecan. For current shipment-level data, contact TransData Nexus.